scispace - formally typeset
K

Kwang Hyub Han

Researcher at Yonsei University

Publications -  694
Citations -  36674

Kwang Hyub Han is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis B virus. The author has an hindex of 80, co-authored 692 publications receiving 30974 citations. Previous affiliations of Kwang Hyub Han include University Health System.

Papers
More filters
Journal ArticleDOI

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

Hye Won Lee, +8 more
- 25 Nov 2016 - 
TL;DR: In patients exhibiting suboptimal responses to ADV+NA therapy for NA-resistant CHB, switching from ADV to TDF might provide better virological outcomes.

Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma

Hyejung Cha, +5 more
TL;DR: In this paper, a retrospective analysis was done for 138 HCC patients treated with CCRT between May 2001 and November 2009, and the authors identified risk factors that could predict treatment failure.
Journal ArticleDOI

Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility Study

Sung Il Park, +11 more
- 01 Oct 2016 - 
TL;DR: Using an angled cool-tip electrode for radiofrequency ablation of small superficial subcapsular liver tumors abutting abdominal wall may be a feasible technique for obtaining adequate ablation margin and lower complication rate.
Journal ArticleDOI

Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha‐foetoprotein and 18F‐fluoro‐2‐deoxyglucose positron emission tomography

Woo Joong Rhee, +5 more
- 01 Apr 2017 - 
TL;DR: The significance of 18F‐fluoro‐2‐deoxyglucose positron emission tomography parameters and alpha‐foetoprotein levels in patients with locally advanced hepatocellular carcinoma (LA‐HCC) is investigated.
Journal ArticleDOI

Multimodality treatment with radiotherapy for huge hepatocellular carcinoma.

Hee Ji Han, +5 more
- 01 Jan 2014 - 
TL;DR: Although huge HCC presents an aggressive clinical course, multimodality approaches involving RT can offer an opportunity for prolonged survival.